Long-Term Outcome Profile in Patients With Acquired Hemophilia A
Underlying lymphoproliferative syndromes, male gender, and older age may be predictive of relapse in patients with acquired hemophilia A.
All articles by John Schieszer, MA
The Efficacy of Intrabone Gene Therapy for Transfusion-Dependent Beta Thalassemia
Allogeneic HSC gene therapy may be an alternative to transplantation for patients with transfusion-dependent thalassemia.
Intravenous Iron May Reduce Coagulability in Patients With Iron Deficiency Anemia
Patients with iron deficiency anemia who were treated with intravenous iron experienced significant changes in parameters measuring coagulability.
Deferasirox May Improve Survival Outcomes in Patients With Acute Myeloid Leukemia
Additionally, hyperferritinemia both before and after transplant was found to have negative prognostic value.
Developing Personalized Treatment Strategies for Patients With Multiple Myeloma
Advances in genetic and molecular assessment strategies have led to improved outcomes for patients with multiple myeloma.
New B Progenitor Acute Lymphoblastic Leukemia Subtypes Identified
The identification of 8 new subtypes of B progenitor acute lymphoblastic leukemia may guide the diagnosis and development of more effective targeted therapies.
A Serological Tool to Phenotypically Characterize Primary Antiphospholipid Syndrome
Researchers assessed the prevalence of various antiphosphatidylserine/prothrombin antibodies in patients with primary antiphospholipid syndrome.
Chemotherapy Intensification May Not Improve Outcomes in Patients With B Cell Acute Lymphoblastic Leukemia
Researchers assessed the influence of cyclophosphamide plus etoposide on disease-free survival in patients with B-cell acute lymphoblastic leukemia.
A Novel Relapse Risk Stratification Model for Patients With Diffuse Large B-Cell Lymphoma
Researchers combined the International Prognostic Index with cell-of-origin subtype to identify patients at high risk for central nervous system relapse.
Luspatercept May Improve Hemoglobin Levels in Patients With Beta Thalassemia
A high percentage of patients with beta thalassemia demonstrated an increase in hemoglobin levels after receiving luspatercept.
Next post in Thalassemias
